The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases
Abstract
BACKGROUND: It is believed that BRCA1 and BRCA2 germline mutations account for the majority of hereditary ovarian carcinomas; however, to the authors' knowledge, there are scant data on the prevalence and spectrum of mutations, genotype/phenotype correlations, tumor histology, and family history characteristics. To address this gap, the authors conducted a population‐based study of 232 incident epithelial ovarian carcinomas in the Tampa Bay area. METHODS: Genetic testing for the BRCA1 and BRCA2 genes was performed through full sequencing and BRCA1 rearrangement testing. RESULTS: Of 209 women with invasive ovarian carcinoma, 32 women (15.3%) had mutations in BRCA1 or BRCA2, including 20 BRCA1 mutations and 12 BRCA2 mutations. Of the BRCA2 mutations, 58% were outside the “ovarian cancer cluster region” (OCCR). Variants of uncertain significance were detected in 8.2% of women with invasive ovarian carcinoma. No mutations were identified in women with borderline or invasive mucinous tumors. Among the BRCA mutation‐positive women, 63% had serous tumors. A family history of breast and/or ovarian carcinoma was reported in 65%, 75%, and 43.5% of relatives of BRCA1 carriers, BRCA2 carriers, and non‐BRCA1/BRCA2 carriers, respectively. CONCLUSIONS: The data from this study suggested that 1) previous studies may have underestimated the frequency of BRCA1 and BRCA2 mutations in ovarian carcinomas, especially outside the OCCR; 2) it may be reasonable to offer genetic counseling to any woman with an invasive, nonmucinous epithelial ovarian tumor; and 3) among patients with invasive ovarian carcinoma, family history is not sufficiently accurate to predict mutation status. Cancer 2005. © 2005 American Cancer Society.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Inherited BRCA1/2 mutations account for an estimated 2–7% of breast cancers and 10–15% of ovarian cancers [3, 5, 6].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1968) · American Association of Industrial Nurses Journal · doi:10.1177/216507996801601208 · Cited by 8,798
WHO handbook for reporting results of cancer treatment
Sylvester, R. (1980) · Controlled Clinical Trials · doi:10.1016/0197-2456(80)90009-4 · Cited by 1,055
Risch, H. A., McLaughlin, J. R., Cole, D. E. C., Rosen, B., Bradley, L., Kwan, E., Jack, E., Vesprini, D. J., Kuperstein, G., Abrahamson, J. L. A., et al. (2001) · The American Journal of Human Genetics · doi:10.1086/318787 · Cited by 986
Principles and Practice of Gynecologic Oncology
Moore, W. (1997) · International Journal of Gynecological Pathology · doi:10.1097/00004347-199707000-00022 · Cited by 838
Frank, T. S. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.6.1480 · Cited by 812
Frank, T. S., Deffenbaugh, A. M., Reid, J. E., Hulick, M., Ward, B. E., Lingenfelter, B., Gumpper, K. L., Scholl, T., Tavtigian, S. V., Pruss, D. R., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.20.6.1480 · Cited by 558
Clinicopathologic Features of <EMPH TYPE="ITAL">BRCA</EMPH>-Linked and Sporadic Ovarian Cancer
Boyd, J. (2000) · JAMA · doi:10.1001/jama.283.17.2260 · Cited by 536
Frank, T. S., Manley, S. A., Olopade, O. I., Cummings, S., Garber, J. E., Bernhardt, B., Antman, K., Russo, D., Wood, M. E., Mullineau, L., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.7.2417 · Cited by 455
Improved survival in women with BRCA‐associated ovarian carcinoma
Cass, I., Baldwin, R. L., Varkey, T., Moslehi, R., Narod, S. A., & Karlan, B. Y. (2003) · Cancer · doi:10.1002/cncr.11310 · Cited by 433
BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients
Petrij-Bosch, A., Peelen, T., van Vliet, M., Eijk, R. V., Olmer, R., Drüsedau, M., Hogervorst, F. B. L., Hageman, S., Arts, P. J. W., Ligtenberg, M. J. L., et al. (1997) · Nature Genetics · doi:10.1038/ng1197-341 · Cited by 432
Goldgar, D. E., Easton, D. F., Deffenbaugh, A. M., Monteiro, A. N. A., Tavtigian, S. V., & Couch, F. J. (2004) · The American Journal of Human Genetics · doi:10.1086/424388 · Cited by 391
Modan, B., Hartge, P., Hirsh-Yechezkel, G., Chetrit, A., Lubin, F., Beller, U., Ben-Baruch, G., Fishman, A., Menczer, J., Struewing, J. P., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200107263450401 · Cited by 385
The accuracy of patient reports of a family history of cancer
Love, R. R., Evans, A. M., & Josten, D. M. (1985) · Journal of Chronic Diseases · doi:10.1016/0021-9681(85)90074-8 · Cited by 251
Contribution of BRCA1 Mutations to Ovarian Cancer
Stratton, J. F., Gayther, S. A., Russell, P., Dearden, J., Gore, M., Blake, P., Easton, D., & Ponder, B. A. J. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704173361602 · Cited by 237
Rubin, S. C., Blackwood, M. A., Bandera, C., Behbakht, K., Benjamin, I., Rebbeck, T. R., & Boyd, J. (1998) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(98)70476-4 · Cited by 179
Frequency of germline and somatic BRCA1 mutations in ovarian cancer.
Berchuck, A., Heron, K., Carney, M. E., Lancaster, J., Fraser, E. G., Vinson, V. L., Deffenbaugh, A. M., Miron, A., Marks, J. R., Futreal, P. A., et al. (1998) · PubMed · Cited by 169
How Accurate is Self-Reported Family History of Colorectal Cancer?
Aitken, J., Bain, C., Ward, M., Siskind, V., & MacLennan, R. (1995) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a117522 · Cited by 158
Unger, M. A., Nathanson, K. L., Calzone, K., Antin-Ozerkis, D. E., Shih, H. A., Martin, A., Lenoir, G., Mazoyer, S., & Weber, B. L. (2000) · The American Journal of Human Genetics · doi:10.1086/303076 · Cited by 157
Bewtra, C., Watson, P. A., Conway, T., Hippee, C. R., & Lynch, H. T. (1992) · International Journal of Gynecological Pathology · doi:10.1097/00004347-199207000-00003 · Cited by 120
Prevalence of founderBRCA1 andBRCA2 mutations among breast and ovarian cancer patients in hungary
van der Looij, M., Szabo, C., Besznyák, I., Liszka, G., Csókay, B., Pulay, T., Tóth, J., Devilee, P., King, M., & Oláh, E. (2000) · International Journal of Cancer · Cited by 104
Mazoyer, S. (2000) · The American Journal of Human Genetics · doi:10.1086/302974 · Cited by 99
One in 10 ovarian cancer patients carry germ line BRCA1 or BRCA2 mutations
Malander, S., Ridderheim, M., Måsbäck, A., Loman, N., Kristoffersson, U., Olsson, H. L., Nilbert, M. C., & Borg, Å. (2003) · European Journal of Cancer · doi:10.1016/j.ejca.2003.09.016 · Cited by 92
Hereditary ovarian cancer in Poland
Menkiszak, J., Gronwald, J., Górski, B., Jakubowska, A., Huzarski, T., Byrski, T., Foszczyńska‐Kłoda, M., Haus, O., Janiszewska, H., Ratajska, M., et al. (2003) · International Journal of Cancer · doi:10.1002/ijc.11338 · Cited by 88
Characteristics Relating to Ovarian Cancer Risk: Implications for Prevention and Detection
Whittemore, A. S. (1994) · Gynecologic Oncology · doi:10.1006/gyno.1994.1334 · Cited by 81
Matsushima, M., Kobayashi, K., Eml, M., et al. (1995) · Human Molecular Genetics · doi:10.1093/hmg/4.10.1953 · Cited by 81
Characteristics of BRCA1 mutations in a population-based case series of breast and ovarian cancer
Anton‐Culver, H., Cohen, P., Gildea, M., & Ziogas, A. (2000) · European Journal of Cancer · doi:10.1016/s0959-8049(00)00110-6 · Cited by 80
Rohlfs, E. M., Puget, N., Graham, M. L., Weber, B. L., Garber, J. E., Skrzynia, C., Halperin, J. R., Lenoir, G., Silverman, L. M., & Mazoyer, S. (2000) · Genes Chromosomes and Cancer · doi:10.1002/1098-2264(200007)28:3<300::aid-gcc8>3.0.co;2-1 · Cited by 80
Genetic heterogeneity of breast-ovarian cancer revisited. Breast Cancer Linkage Consortium.
Narod, S. A., Ford, D., Devilee, P., Barkardottir, R. B., Eyfjord, J. E., Lenoir, G., Serova, O., Easton, D. F., & Goldgar, D. E. (1995) · Europe PMC (PubMed Central) · Cited by 75
Petrucelli, N., Lazebnik, N., Huelsman, K. M., & Lazebnik, R. S. (2002) · Genetic Testing · doi:10.1089/10906570260199357 · Cited by 74
Piek, J. M. J., Torrenga, B., Hermsen, B. B. J., Verheijen, R. H. M., Zweemer, R. P., Gille, J. J. P., Kenemans, P., van Diest, P. J., & Menko, F. H. (2003) · Familial Cancer · doi:10.1023/a:1025700807451 · Cited by 66
Rafnar, Þ., Benediktsdóttir, K. R., Eldon, B., Gestsson, T., Saemundsson, H., Olafsson, K., Salvarsdottir, A., Steingrı́msson, E., & Thorlacius, S. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2004.09.008 · Cited by 62
BRCA1 mutations in ovarian cancer and borderline tumours in Norway: a nested case–control study
Bjørge, T., Lie, A. K., Hovig, E. J., Gislefoss, R. E., Hansen, S., Jellum, E., Langseth, H., Nustad, K., Tropé, C. G., & Dørum, A. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6602199 · Cited by 57
Rates of Jewish Ancestral Mutations in BRCAI and BRCA2 in Borderline Ovarian Tumors
Gotlieb, W. H., Ben‐Baruch, G., Friedman, E., Bar-Sade, R. B., Сергеевна, К. А., Hirsh‐Yechezkel, G., Modan, B., Novikov, I., Davidson, B., Kopolovic, J., et al. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.13.995 · Cited by 50
Cited by
Integrated genomic analyses of ovarian carcinoma
Perou, C. M. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/hvp3-wg08 · Cited by 7,925
Epidemiology of ovarian cancer: a review
Brett M., R., Brett M., R., Jennifer B., P., Thomas A., S., Jennifer B., P., & Thomas A., S. (2017) · Cancer Biology & Medicine · doi:10.20892/j.issn.2095-3941.2016.0084 · Cited by 1,524
Ledermann, J., Harter, P., Gourley, C., Friedlander, M., Vergote, I., Rustin, G., Scott, C. L., Meier, W., Shapira-Frommer, R., Safra, T., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70228-1 · Cited by 1,442
Alsop, K., Fereday, S., Meldrum, C., deFazio, A., Emmanuel, C., George, J., Dobrovic, A., Birrer, M. J., Webb, P. M., Stewart, C., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.39.8545 · Cited by 1,180
Daly, M. B., Pal, T., Berry, M. P., Buys, S. S., Dickson, P., Domchek, S. M., Elkhanany, A., Friedman, S., Goggins, M., Hutton, M. L., et al. (2021) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2021.0001 · Cited by 1,112
Self-citation
Metadata
- Authors
- Pal, T., Permuth‐Wey, J., Betts, J. A., Krischer, J. P., Fiorica, J., Arango, H., LaPolla, J., Hoffman, M., Martino, M. A., Wakeley, K., Wilbanks, G., Nicosia, S., Cantor, A., & Sutphen, R.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2005-11-14
- Volume
- 104
- Issue
- 12
- Pages
- 2807-2816
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W1484356204
- Cited by
- 691
- References
- 33
- FWCI
- 7.39
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.